The Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) project is a randomized, placebo-controlled clinical trial seeking to evaluate the clinical efficacy of the antiviral drug Ensitrelvir when given in addition to the standard of care for hospitalized patients with COVID-19.
STRIVE
The Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) project is a randomized, placebo-controlled clinical trial seeking to evaluate the clinical efficacy of the antiviral drug Ensitrelvir when given in addition to the standard of care for hospitalized patients with COVID-19. The research to provide alternative and more effective treatment for the management of moderate to severe COVID-19.
Over 30 countries are participating in the study - IHVN in collaborating with two sites (University of Abuja Teaching Hospital Gwagwalada and Nisa-Garki Hospital, Garki, Abuja) representing the Nigerian site.
Global Principal Investigator : Prof Jens Lundgren, Nigerian Principal Investigator: Dr Nnakelu Eriobu Co-Investigators: Dr Onu Adamu and Dr Vivian Kwaghe
Project Funders and collaborators: NIH
Project Duration: 2023-2028